Imbrium Therapeutics Email Format

Biotechnology ResearchConnecticut, United States11-50 Employees

Imbrium Therapeutics is a clinical-stage biotechnology company focused on developing new pharmacologic and biologic therapeutics to address oncology, central nervous system disorders, and non-opioid approaches to pain management. Operating as a subsidiary of Purdue Pharma L.P., the firm pursues a diversified pipeline and collaborates with industry and academic partners to identify and advance potential medicines for unmet patient needs. Based in Stamford, Connecticut, the company positions itself within the biotechnology research sector and emphasizes early development and collaboration rather than marketed products at this stage. Imbrium’s activities include pursuing non-opioid treatments for conditions such as interstitial cystitis/bladder pain syndrome, and it has historically engaged in partnerships related to its research programs through its collaborations.

Get verified Imbrium Therapeutics emails free

Company overview Employee directory